Actively Recruiting
Effects of Combined vs. Sequential Attentional Focus Instructions on Upper Extremity Function in Subacute Stroke
Led by Bahçeşehir University · Updated on 2026-01-20
36
Participants Needed
1
Research Sites
82 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Stroke is a leading cause of long-term disability, and upper extremity impairments-affecting about 80% of survivors-limit functional reach, grasp, and manipulation more severely than lower limb deficits. Despite partial recovery of walking ability, meaningful functional use of the paretic arm remains limited. Conventional rehabilitation often lacks sufficient intensity, task specificity, and motor learning principles, highlighting the need for more effective approaches. The subacute phase of stroke (up to 6 months post-onset) represents a period of heightened neuroplasticity and strong rehabilitation potential. During this time, integrating cognitive and motor training-such as attentional focus strategies-has gained attention. External focus enhances movement efficiency through motor automaticity, whereas internal focus supports early motor control. Evidence suggests that combining these strategies may optimize recovery, yet their relative effectiveness in stroke rehabilitation remains unclear. Two main instructional approaches exist: combined attentional focus (internal and external cues delivered within the same session) and sequential attentional focus (internal focus first, followed by external focus as control improves). While both show therapeutic promise, comparative data in stroke populations are lacking. This study aims to compare combined versus sequential attentional focus instructions in improving upper extremity function in subacute stroke. We hypothesize that a combined approach-starting with internal focus early, then integrating external focus-will yield superior motor improvements.
CONDITIONS
Official Title
Effects of Combined vs. Sequential Attentional Focus Instructions on Upper Extremity Function in Subacute Stroke
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 40 and 80 years at enrollment
- Stroke diagnosis by a neurologist between 1 week and 6 months before enrollment
- Medically stable with controlled and non-fluctuating vital signs
- Sufficient cognitive function to follow instructions and participate actively in rehabilitation
- Brunnstrom stage 2 to 5 in the affected upper limb
- Modified Ashworth Scale score less than 3 in both upper and lower extremities
- Preserved corticospinal tract integrity confirmed by positive Motor Evoked Potential response
- Moderate to severe upper-extremity motor impairment with Fugl-Meyer Assessment scores from 0 to 47
You will not qualify if you...
- Modified Ashworth Scale score 3 or higher in either upper or lower extremities
- Current or recent fracture on the affected side of the body
- Botulinum toxin (Botox) injections within the previous three months
- Motor or global aphasia or other communication impairments interfering with understanding or task performance
- Concurrent rehabilitation treatment at another facility
- Failure to attend all required treatment sessions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Neur-On Clinic, İstinye University, Bahcesehir Liv Hospital Stroke Center
Istanbul, Turkey (Türkiye), 34517
Actively Recruiting
Research Team
P
Pelin Pisirici, PT, PhD
CONTACT
E
Emirhan Kocer, PT
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here